Evaluation of Role of exercise in women undergoing treatment for breast cancer.

Randomized controlled trial Evaluating the role of exercise in women undergoing treatment for breast cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036604

Enrollment

850

Registered

2021-09-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast Health Condition 2: null- Nonmetastatic operable breast cancer

Interventions

Intervention1: Yogic and Routine exrcises (exercise I): Exercise I arm (Yoga and conventional exercises) patients will begin the exercises within a week of starting treatment. Patients will be upgrade

6 months f, 12 months, 18 months, 36 months and 54 months.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women with unilateral breast cancer 2. Age 18-65 years

Exclusion criteria

Exclusion criteria: 1. Metastatic breast cancer 2. Pregnant Women 3. Women with physical limitations to perform exercises 4. Previous history of cancer

Design outcomes

Primary

Measure	Time frame
Disease-free survivalTimepoint: 5 years	—

Secondary

Measure	Time frame
Quality of life Improvements in overall survival Improvements in Lung Function. Timepoint: 5 years	—

Countries

India

Contacts

Public ContactDr Nita Nair

Tata Memorial Hospital

nitanair@hotmail.com912224177194

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026